Culture Development Featured Articles
-
Roche And BioLamina Start Collaboration To Develop Novel Cell Culture Systems
3/6/2013
BioLamina, Stockholm, Sweden and Roche recently announced the signing of a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research.
-
Top Pharma And Biotech Firms Trust CompacT Automated Cell Culture To Generate Their Cell Lines
1/11/2013
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications today announced that with its latest installation of CompacT SelecT™, the technology remains the most widely adopted system for automated culture of adherent cell lines in T-flasks, used by major pharmaceutical and biotech companies worldwide.
-
Evotec Acquires Cell Culture Service GmbH
1/3/2013
Evotec AG recently announced the acquisition of all shares in Cell Culture Service GmbH (CCS), a Hamburg-based company which supports the cell culture needs of a world-wide customer base of biotech and Pharmaceutical companies.
-
Lonza And Sartorius Stedim Biotech Enter Collaboration, Supply And Distribution Agreement In The Field Of Cell Culture Media
12/19/2012
Lonza recently announced together with Sartorius Stedim Biotech (SSB), a leading international pharmaceutical and biotech supplier, a long-term global collaboration, supply and distribution agreement in the field of cell culture media.
-
3D Cell Culture Firm Reinnervate Announce The Release Of Alvetex Scaffold 96 Well Plates For High Throughput 3D Cell-Based Assays
12/13/2012
Market leading 3D cell culture company, Reinnervate Ltd, recently announced that it has launched and commenced shipments of Alvetex Scaffold 96 well plates to customers.
-
TAP Collaborates With CCRM On Process Optimisation Project For Cell Therapies
12/3/2012
TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, has joined the Centre for Commercialization of Regenerative Medicine’s (CCRM) industry consortium to translate laboratory cell culture conditions into optimized processes and media for commercial production of cellular therapies.
-
FDA Approves First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology
11/20/2012
The U.S. Food and Drug Administration announced recently the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs. Flucelvax is approved to prevent seasonal influenza in people ages 18 years and older.
-
GE Healthcare launches modular biopharmaceutical factory, KUBio
9/4/2012
GE Healthcare, the healthcare business of GE, today introduced KUBio™, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money. KUBio’s pre-made modules, which are assembled at a customer’s chosen site to make a fully functional ready-to-run bioprocessing facility, are significantly faster to install than constructing a traditional factory.
-
WHEATON Announces Acquisition Of CELLine
7/9/2012
WHEATON has acquired the CELLine dual membrane, cell culture flasks from Wilson Wolf Manufacturing Corporation. WHEATON has also entered into a long term strategic partnership with Wilson Wolf Manufacturing Corporation for further product development in high density cell culture devices for the production of concentrated, cell secreted products.
-
CFDRC Developing Cell-Based Microchip To Study Drug Interactions With The Blood-Brain Barrier
6/21/2012
CFD Research Corporation (CFDRC) has been awarded a $1.3M grant from the National Institutes of Health to further develop their novelin vitro Blood-Brain Barrier model. Building upon CFDRC's patented and commercially available SynVivo platform, SynVivo-BBB is a cell-based microchip which allows co-culture of endothelial cells under physiological flow with neuronal and glial cells mimicking the in vivo environment.